Protalix BioTherapeutics, Inc. (PLX) Stock News, Earnings & History

(AMEX:PLX) Healthcare

Enjoy Interactive Tools and Indicators

52wk high: 6.80
52wk low: 4.71
EPS: -0.11
P/E: N/A
Div Rate: N/A
Yield: N/A
Market Cap: 479.36M
Avg Vol (3m): 165,022

Insider Trading Cheat Sheet

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Akirov Alfred Director Mar 12 Sale 5.70 10,000 57,000 5,027,713 Mar 14 07:00 PM
Akirov Alfred Director Mar 11 Sale 5.72 18,300 104,737 5,037,711 Mar 12 06:30 PM
Akirov Alfred Director Mar 08 Sale 5.86 16,898 99,068 5,056,013 Mar 12 06:30 PM
Akirov Alfred Director Mar 07 Sale 5.72 8,435 48,233 5,072,911 Mar 08 05:04 PM
Akirov Alfred Director Mar 06 Sale 5.69 4,700 26,737 5,081,346 Mar 08 05:04 PM
Aviezer David President & CEO May 02 Option Exercise 0.35 450,000 159,421 450,000 May 04 05:11 PM
Maimon Yossi VP, Chief Financial Officer May 02 Option Exercise 1.64 125,964 206,337 125,964 May 04 05:13 PM
Almon Einat Brill SVP, Product Development May 02 Option Exercise 1.47 166,848 246,076 166,848 May 04 05:10 PM
Shaaltiel Yoseph Executive VP, R&D May 02 Sale 7.13 300,000 2,139,000 463,754 May 04 05:14 PM
Maimon Yossi VP, Chief Financial Officer May 02 Sale 7.13 125,964 898,123 0 May 04 05:13 PM
Yahoo, HV, Market Watch, The Wall St. Journal